日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma

髓系肉瘤的多组学表征、早期检测和治疗靶向

Nadorp, Bettina; Lasry, Audrey; Loghavi, Sanam; Patel, Ravi; Mansour, Hager; Kelly, Benjamin J; Walker, Christopher J; Buss, Jill; Boateng, Isaiah; Al-Santli, Wafa; Ciantra, Zoe; Austin, Rebecca; Heyrosa, Adrienne; Desai, Helee; Laganson, Andrea; Abaza, Hasan; Procell, Linda; Patel, Tejas; Kaffenberger, Benjamin; Wijeratne, Saranga; Guillamot, Maria; Velegraki, Maria; Chiriboga, Luis; Li, Zihai; Abruzzo, Lynne V; Pollyea, Daniel A; McMahon, Christine; Shana'ah, Arwa; Byrd, John C; Shih, Alan; Levine, Ross L; Papapetrou, Eirini P; Tsirigos, Aristotelis; Mardis, Elaine R; Mims, Alice S; Aifantis, Iannis; Eisfeld, Ann-Kathrin

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Duvelisib联合罗米地辛治疗复发/难治性T细胞淋巴瘤:一项1b/2a期试验

Steven M Horwitz ,Ajit J Nirmal ,Jahan Rahman # ,Ran Xu # ,Esther Drill ,Natasha Galasso ,Nivetha Ganesan ,Theresa Davey ,Helen Hancock ,Leslie Perez ,Catherine Maccaro ,Alexandra Bahgat ,Evan Marzouk ,Elizabeth Cathcart ,Alison Moskowitz ,Ariela Noy ,Anita Kumar ,Eric Jacobsen ,David C Fisher ,Neha Mehta-Shah ,Youn H Kim ,Michael Khodadoust ,Nikita Kotlov ,Anastasia Nikitina ,Olga Kudryashova ,Valeria Zubareva ,Ksenia Zornikova ,Nara Shin ,Maria Sorokina ,Sandrine Degryse ,Ekaterina Postovalova ,Aleksander Bagaev ,Kinga Hosszu ,Devin McAvoy ,Jaap J Boelens ,Wenchao Wu ,Zoe Ciantra ,Jackson W Appelt ,Christopher Trevisani ,Sam Amaka ,David M Weinstock ,Santosha A Vardhana

A membrane-associated MHC-I inhibitory axis for cancer immune evasion

肿瘤免疫逃逸的膜相关MHC-I抑制轴

Xufeng Chen ,Qiao Lu ,Hua Zhou ,Jia Liu ,Bettina Nadorp ,Audrey Lasry ,Zhengxi Sun ,Baoling Lai ,Gergely Rona ,Jiangyan Zhang ,Michael Cammer ,Kun Wang ,Wafa Al-Santli ,Zoe Ciantra ,Qianjin Guo ,Jia You ,Debrup Sengupta ,Ahmad Boukhris ,Hongbing Zhang ,Cheng Liu ,Peter Cresswell ,Patricia L M Dahia ,Michele Pagano ,Iannis Aifantis ,Jun Wang

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial

新辅助纳武利尤单抗或纳武利尤单抗联合伊匹木单抗治疗未经治疗的口腔鳞状细胞癌:一项 II 期开放标签随机临床试验

Schoenfeld, Jonathan D; Hanna, Glenn J; Jo, Vickie Y; Rawal, Bhupendra; Chen, Yu-Hui; Catalano, Paul S; Lako, Ana; Ciantra, Zoe; Weirather, Jason L; Criscitiello, Shana; Luoma, Adrienne; Chau, Nicole; Lorch, Jochen; Kass, Jason I; Annino, Donald; Goguen, Laura; Desai, Anupam; Ross, Brendan; Shah, Hina J; Jacene, Heather A; Margalit, Danielle N; Tishler, Roy B; Wucherpfennig, Kai W; Rodig, Scott J; Uppaluri, Ravindra; Haddad, Robert I